-
1
-
-
0033134701
-
Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
-
DOI 10.1016/S0002-9343(99)00063-7, PII S0002934399000637
-
F. Grodstein P.A. Newcomb M.J. Stampfer 1999 Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis Am J Med 106 5 574 582 10.1016/S0002-9343(99)00063-7 1:STN:280:DyaK1M3ms1OlsA%3D%3D 10335731 (Pubitemid 29231110)
-
(1999)
American Journal of Medicine
, vol.106
, Issue.5
, pp. 574-582
-
-
Grodstein, F.1
Newcomb, P.A.2
Stampfer, M.J.3
-
2
-
-
0032725294
-
Estrogen replacement therapy and colon cancer: A clinical review
-
1:STN:280:DC%2BD3c%2FmtFOjsQ%3D%3D
-
C.J. Crandall 1999 Estrogen replacement therapy and colon cancer: a clinical review J Women's Healt h Gend Based Med 8 9 1155 1166 1:STN:280:DC%2BD3c%2FmtFOjsQ%3D%3D
-
(1999)
J Women's Healt H Gend Based Med
, vol.8
, Issue.9
, pp. 1155-1166
-
-
Crandall, C.J.1
-
3
-
-
0034024259
-
Menopause and colorectal cancer
-
10.1054/bjoc.1999.1084 1:STN:280:DC%2BD3c3ps1WisA%3D%3D 10839302
-
S. Franceschi S. Gallus R. Talamini, et al. 2000 Menopause and colorectal cancer Br J Cancer 82 11 1860 1862 10.1054/bjoc.1999.1084 1:STN:280: DC%2BD3c3ps1WisA%3D%3D 10839302
-
(2000)
Br J Cancer
, vol.82
, Issue.11
, pp. 1860-1862
-
-
Franceschi, S.1
Gallus, S.2
Talamini, R.3
-
4
-
-
0032918794
-
Hormone replacement therapy and the risk of colorectal cancer: A meta- analysis
-
DOI 10.1016/S0029-7844(98)00424-4, PII S0029784498004244
-
K. Nanda L.A. Bastian V. Hasselblad, et al. 1999 Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis Obstet Gynecol 93 5 880 888 10.1016/S0029-7844(98)00424-4 1:STN:280:DC%2BD3czovVyktw%3D%3D 10912438 (Pubitemid 29197937)
-
(1999)
Obstetrics and Gynecology
, vol.93
, Issue.SUPPL.
, pp. 880-888
-
-
Nanda, K.1
Bastian, L.A.2
Hasselblad, V.3
Simel, D.L.4
-
5
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
WHI. 10.1001/jama.288.3.321
-
WHI. 2002 Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women JAMA 288 3 321 333 10.1001/jama.288.3.321
-
(2002)
JAMA
, vol.288
, Issue.3
, pp. 321-333
-
-
-
6
-
-
0022473069
-
Sequence and expression of human estrogen receptor complementary DNA
-
10.1126/science.3753802 1:CAS:528:DyaL28XhvVSqs70%3D 3753802
-
G.L. Greene P. Gilna M. Waterfield, et al. 1986 Sequence and expression of human estrogen receptor complementary DNA Science 231 4742 1150 1154 10.1126/science.3753802 1:CAS:528:DyaL28XhvVSqs70%3D 3753802
-
(1986)
Science
, vol.231
, Issue.4742
, pp. 1150-1154
-
-
Greene, G.L.1
Gilna, P.2
Waterfield, M.3
-
8
-
-
0030593681
-
ERβ: Identification and characterization of a novel human estrogen receptor
-
DOI 10.1016/0014-5793(96)00782-X
-
S. Mosselman J. Polman R. Dijkema 1996 ERβ: identification and characterization of a novel estrogen receptor FEBS Lett 392 1 49 53 10.1016/0014-5793(96)00782-X 1:CAS:528:DyaK28Xlt1Kjurg%3D 8769313 (Pubitemid 26268330)
-
(1996)
FEBS Letters
, vol.392
, Issue.1
, pp. 49-53
-
-
Mosselman, S.1
Polman, J.2
Dijkema, R.3
-
9
-
-
0036887763
-
Human oestrogen receptors: Differential expression of ERalpha and beta and the identification of ERbeta variants
-
DOI 10.1016/S0039-128X(02)00047-8, PII S0039128X02000478
-
G.A. Scobie S. Macpherson M.R. Millar, et al. 2002 Human estrogen receptors: differential expression of ER alpha and beta and the identification of ERbeta variants Steroids 67 12 985 992 10.1016/S0039-128X(02)00047-8 1:CAS:528:DC%2BD38XotVeqt78%3D 12398995 (Pubitemid 35175466)
-
(2002)
Steroids
, vol.67
, Issue.12
, pp. 985-992
-
-
Scobie, G.A.1
Macpherson, S.2
Millar, M.R.3
Groome, N.P.4
Romana, P.G.5
Saunders, P.T.K.6
-
10
-
-
0035024422
-
Expression and cellular localization of estrogen receptors α and β in the human fetus
-
DOI 10.1210/jc.86.5.2258
-
J. Takeyama T. Suzuki S. Inoue, et al. 2001 Expression and cellular localization of estrogenreceptors alpha and beta in the human fetus J Clin Endocrinol Metab 86 5 2258 2262 10.1210/jc.86.5.2258 1:CAS:528: DC%2BD3MXjs1Omtbg%3D 11344236 (Pubitemid 32472949)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.5
, pp. 2258-2262
-
-
Takeyama, J.1
Suzuki, T.2
Inoue, S.3
Kaneko, C.4
Nagura, H.5
Harada, N.6
Sasano, H.7
-
12
-
-
0034783960
-
Mechanisms of estrogen action
-
1:CAS:528:DC%2BD38XislCqtw%3D%3D 11581496
-
S. Nilsson S. Makela E. Treuter, et al. 2001 Mechanisms of estrogen action Physiol Rev 81 4 1535 1565 1:CAS:528:DC%2BD38XislCqtw%3D%3D 11581496
-
(2001)
Physiol Rev
, vol.81
, Issue.4
, pp. 1535-1565
-
-
Nilsson, S.1
Makela, S.2
Treuter, E.3
-
13
-
-
0035878743
-
Estrogen receptor interaction with estrogen response elements
-
10.1093/nar/29.14.2905 1:CAS:528:DC%2BD3MXlslCktbY%3D 11452016
-
C.M. Klinge 2001 Estrogen receptor interaction with estrogen response elements Nucleic Acids Res 29 14 2905 2919 10.1093/nar/29.14.2905 1:CAS:528:DC%2BD3MXlslCktbY%3D 11452016
-
(2001)
Nucleic Acids Res
, vol.29
, Issue.14
, pp. 2905-2919
-
-
Klinge, C.M.1
-
14
-
-
0034520584
-
Novel agents to modulate oestrogen action
-
DOI 10.1258/0007142001903355
-
R.C. Dardes V.C. Jordan 2000 Novel agents to modulate estrogen action Br Med Bull 56 3 773 786 10.1258/0007142001903355 1:CAS:528:DC%2BD3MXot1Gjtw%3D%3D 11255561 (Pubitemid 32042155)
-
(2000)
British Medical Bulletin
, vol.56
, Issue.3
, pp. 773-786
-
-
Dardes, R.C.1
Jordan, V.C.2
-
15
-
-
61649086428
-
Estrogen metabolism and breast cancer: A risk model
-
10.1111/j.1749-6632.2008.03676.x 1:CAS:528:DC%2BD1MXktFKlsbo%3D 19250193
-
F.F. Parl S. Dawling N. Roodi, et al. 2009 Estrogen metabolism and breast cancer: a risk model Ann N Y Acad Sci 1155 68 75 10.1111/j.1749-6632.2008. 03676.x 1:CAS:528:DC%2BD1MXktFKlsbo%3D 19250193
-
(2009)
Ann N y Acad Sci
, vol.1155
, pp. 68-75
-
-
Parl, F.F.1
Dawling, S.2
Roodi, N.3
-
16
-
-
62749085753
-
Breast cancer, estrogen receptor and ligands
-
10.1002/ardp.200800174 1:CAS:528:DC%2BD1MXktVSktrY%3D
-
Z. Bai R. Gust 2009 Breast cancer, estrogen receptor and ligands Arch Pharm (Weinheim) 342 3 133 149 10.1002/ardp.200800174 1:CAS:528: DC%2BD1MXktVSktrY%3D
-
(2009)
Arch Pharm (Weinheim)
, vol.342
, Issue.3
, pp. 133-149
-
-
Bai, Z.1
Gust, R.2
-
17
-
-
0034665412
-
Estrogens, BRCAL and breast cancer
-
L. Hilakrn Clarke 2000 Estrogens, BRCAL and breast cancer Cancer Res 60 18 4993 5001
-
(2000)
Cancer Res
, vol.60
, Issue.18
, pp. 4993-5001
-
-
Hilakrn Clarke, L.1
-
18
-
-
0034099083
-
Hormonal carcinogenesis
-
10.1093/carcin/21.3.427 1:CAS:528:DC%2BD3cXitVeisL4%3D
-
B.E. Henderson H.S. Feigelson 2000 Hormonal carcinogenesis Carcinogensis 21 3 427 433 10.1093/carcin/21.3.427 1:CAS:528:DC%2BD3cXitVeisL4%3D
-
(2000)
Carcinogensis
, vol.21
, Issue.3
, pp. 427-433
-
-
Henderson, B.E.1
Feigelson, H.S.2
-
19
-
-
34247595396
-
The interaction of age and hormone replacement therapy on colon adenoma risk
-
DOI 10.1016/j.cdp.2007.03.002, PII S0361090X07000347
-
H.J. Murff M.J. Shrubsole W.E. Smalley, et al. 2007 The interaction of age and hormone replacement therapy on colon adenoma risk Cancer Detect Prev 31 2 161 165 10.1016/j.cdp.2007.03.002 17433566 (Pubitemid 46669819)
-
(2007)
Cancer Detection and Prevention
, vol.31
, Issue.2
, pp. 161-165
-
-
Murff, H.J.1
Shrubsole, M.J.2
Smalley, W.E.3
Wu, H.4
Shyr, Y.5
Ness, R.M.6
Zheng, W.7
-
20
-
-
23944475103
-
ERβ isoform expression in colorectal carcinoma: An in vivo and in vitro study of clinicopathological and molecular correlates
-
DOI 10.1002/path.1807
-
N.A. Wong R.D. Malcomson D.I. Jodrell, et al. 2005 ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates J Pathol 207 1 53 60 10.1002/path.1807 1:CAS:528:DC%2BD2MXhtVemtr3N 15954165 (Pubitemid 41200714)
-
(2005)
Journal of Pathology
, vol.207
, Issue.1
, pp. 53-60
-
-
Wong, N.A.C.S.1
Malcomson, R.D.G.2
Jodrell, D.I.3
Groome, N.P.4
Harrison, D.J.5
Saunders, P.T.K.6
-
21
-
-
34548051074
-
Estrogen receptor α inhibits p53-mediated transcriptional repression: Implications for the regulation of apoptosis
-
DOI 10.1158/0008-5472.CAN-06-3724
-
A. Sayeed S.D. Konduri W. Liu, et al. 2007 Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis Cancer Res 67 16 7746 7755 10.1158/0008-5472.CAN-06-3724 1:CAS:528:DC%2BD2sXptVGlsbY%3D 17699779 (Pubitemid 47281368)
-
(2007)
Cancer Research
, vol.67
, Issue.16
, pp. 7746-7755
-
-
Sayeed, A.1
Konduri, S.D.2
Liu, W.3
Bansal, S.4
Li, F.5
Das, G.M.6
-
22
-
-
33747100321
-
Apoptotic effects of over-expressed estrogen receptorbeta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner
-
H.H. Hsu S.F. Cheng C.C. Wu, et al. 2006 Apoptotic effects of over-expressed estrogen receptorbeta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner Chin J Physiol 49 3 167 172
-
(2006)
Chin J Physiol
, vol.49
, Issue.3
, pp. 167-172
-
-
Hsu, H.H.1
Cheng, S.F.2
Wu, C.C.3
-
23
-
-
30344482262
-
Associations between ERα, ERβ, and AR genotypes and colon and rectal cancer
-
DOI 10.1158/1055-9965.EPI-05-0514
-
M.L. Slattery C. Sweeney M. Murtaugh, et al. 2005 Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer Cancer Epidemiol Biomarkers Prev 14 12 2936 2942 10.1158/1055-9965.EPI-05-0514 1:CAS:528:DC%2BD2MXhtlahs7vN 16365013 (Pubitemid 43068828)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.12
, pp. 2936-2942
-
-
Slattery, M.L.1
Sweeney, C.2
Murtaugh, M.3
Ma, K.N.4
Wolff, R.K.5
Potter, J.D.6
Caan, B.J.7
Samowitz, W.8
-
24
-
-
4944246588
-
Loss of ERβ expression as a common step in estrogen-dependent tumor progression
-
DOI 10.1677/erc.1.00800
-
A. Bardin N. Boulle G. Lazennec, et al. 2004 Loss of ERbeta expression as a common step in estrogen-dependent tumor progression Endocrine-Related Cancer 11 3 537 551 10.1677/erc.1.00800 1:CAS:528:DC%2BD2cXpsFCms7c%3D 15369453 (Pubitemid 39331282)
-
(2004)
Endocrine-Related Cancer
, vol.11
, Issue.3
, pp. 537-551
-
-
Bardin, A.1
Boulle, N.2
Lazennec, G.3
Vignon, F.4
Pujol, P.5
-
25
-
-
0038579655
-
Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
-
DOI 10.1016/S0959-8049(03)00239-9
-
P.A. Konstantinopoulos A. Kominea G. Vandoros, et al. 2003 Estrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor's dedifferentiation Eur J Cancer 39 1251 1258 10.1016/S0959-8049(03)00239-9 1:CAS:528: DC%2BD3sXjvFeluro%3D 12763213 (Pubitemid 36579196)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.9
, pp. 1251-1258
-
-
Konstantinopoulos, P.A.1
Kominea, A.2
Vandoros, G.3
Sykiotis, G.P.4
Andricopoulos, P.5
Varakis, I.6
Sotiropoulou-Bonikou, G.7
Papavassiliou, A.G.8
-
26
-
-
2642544592
-
Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter
-
DOI 10.1016/S0092-8674(03)00934-6
-
R. Métivier G. Penot M.R. Hübner, et al. 2003 Estrogen receptor α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 6 751 763 10.1016/S0092-8674(03) 00934-6 14675539 (Pubitemid 38030303)
-
(2003)
Cell
, vol.115
, Issue.6
, pp. 751-763
-
-
Metivier, R.1
Penot, G.2
Hubner, M.R.3
Reid, G.4
Brand, H.5
Kos, M.6
Gannon, F.7
-
27
-
-
8544226964
-
Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer
-
DOI 10.1158/0008-5472.CAN-04-2045
-
Y.W. Leu P.S. Yan M. Fan, et al. 2004 Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer Cancer Res 64 22 8184 8192 10.1158/0008-5472.CAN-04-2045 1:CAS:528:DC%2BD2cXpvVGlur4%3D 15548683 (Pubitemid 39491754)
-
(2004)
Cancer Research
, vol.64
, Issue.22
, pp. 8184-8192
-
-
Leu, Y.-W.1
Yan, P.S.2
Fan, M.3
Jin, V.X.4
Liu, J.C.5
Curran, E.M.6
Welshons, W.V.7
Wei, S.H.8
Davuluri, R.V.9
Plass, C.10
Nephew, K.P.11
Huang, T.H.-M.12
|